Researchers collected 6,091 bacterial isolates from ICU patients with pneumonia in 75 U.S. medical centers from 2015-17 as part of the International Network for Optimal Resistance Monitoring program.
The study shows gram-negative bacteria were isolated from 67.1 percent of the patients. The most common organisms were:
• Staphylococcus aureus: 30 percent
• Pseudomonas aeruginosa: 20.7 percent
• Klebsiella spp.: 11.8 percent
• Enterobacter spp.: 8.3 percent
• Escherichia coli: 7.1 percent
• Stenotrophomonas maltophilia: 5.1 percent
Colistin, ceftazidime/avibactam and ceftolozane/tazobactam were the most active compounds against P. aeruginosa, while Ceftazidime/avibactam, amikacin and meropenem were the most active compounds against Enterobacteriaceae.
More articles on healthcare quality:
Eye exam instruments linked to adenovirus outbreak in NICU
Human tracking of hand hygiene compliance inadequate
American Academy of Pediatrics releases new guidelines for infertility discussion with younger patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.